Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Indutrade makes add-on acquisition within Life Science

Indutrade

Indutrade has signed an agreement to acquire all shares in the Swedish company Aldax AB, www.aldax.se, with annual sales of approximately SEK 50 million.

Aldax is a technical trading company offering miniature fluidic components and instrumentation to the life science sector. The company has a comprehensive product portfolio, including proportional valves, solenoid valves, pumps, regulators, fittings, tubing, and sensors. It also provides subassemblies tailored to specific client needs. The primary customers are medical and analytical instrumentation manufacturers in the Nordics.

Aldax was founded in 1990, has eight employees and is located in Stockholm, Sweden. As an add-on to Indutrade-owned Colly Flowtech in Sweden, the companies’ combined offerings will provide good growth opportunities.

The closing takes place today and Aldax will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's ninth in 2025 and is expected to have a marginally positive impact on Indutrade's earnings per share.

For further information, please contact:
Bo Annvik, President and CEO
Phone +46 8 703 03 00

About Indutrade
Indutrade is an international technology and industrial business group that today consists of over 200 companies in some 30 countries, mainly in Europe. In a decentralised way, we aim to provide sustainable profitable growth by developing and acquiring successful companies managed by passionate entrepreneurs. Our companies develop, manufacture, and sell components, systems and services with significant technical content in selected niches. Our value-based culture, where people make the difference, has been the foundation of our success since the start in 1978. Indutrade's net sales totalled SEK 32.5 billion in 2024, and the share is listed on Nasdaq Stockholm in Sweden.

Attachments
Indutrade makes add-on acquisition within Life Science

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.